Gandorfer, Arnd <br/><br/>
Association between anatomical resolution and functional outcomes in the mivi-trust studies using ocriplasmin to treat symptomatic vitreomacular adhesion/vitreomacular traction, including when associated with macular hole.  [electronic resource] 

 -  Retina (Philadelphia, Pa.)  Jun 2015 
 - 1151-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1539-2864 
<br/><br/><label>Standard No.: </label>10.1097/IAE.0000000000000508  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Double-Blind Method<br/>Eye Diseases--diagnosis<br/>Fibrinolysin--adverse effects<br/>Fibrinolytic Agents--adverse effects<br/>Follow-Up Studies<br/>Humans<br/>Intravitreal Injections<br/>Peptide Fragments--adverse effects<br/>Retinal Diseases--diagnosis<br/>Retinal Perforations--diagnosis<br/>Sickness Impact Profile<br/>Surveys and Questionnaires<br/>Tissue Adhesions--drug therapy<br/>Visual Acuity--physiology<br/>Vitreous Body--drug effects